Fairmount Funds Management as of Dec. 31, 2022
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 16 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axsome Therapeutics (AXSM) | 24.6 | $155M | 2.0M | 77.13 | |
| Nuvalent Inc-a (NUVL) | 13.2 | $83M | 2.8M | 29.78 | |
| Verona Pharma Sponsored Ads (VRNA) | 11.9 | $75M | 2.9M | 26.13 | |
| Beigene Sponsored Adr (BGNE) | 8.4 | $53M | 239k | 219.94 | |
| Miragen Therapeutics (VRDN) | 6.3 | $40M | 1.4M | 29.21 | |
| Neurocrine Biosciences (NBIX) | 5.4 | $34M | 283k | 119.44 | |
| Cogent Biosciences (COGT) | 5.1 | $32M | 2.8M | 11.56 | |
| BioCryst Pharmaceuticals (BCRX) | 4.6 | $29M | 2.5M | 11.48 | |
| Astria Therapeutics (ATXS) | 4.5 | $28M | 1.9M | 14.89 | |
| Argenx Se Sponsored Adr (ARGX) | 4.4 | $28M | 74k | 378.83 | |
| Terns Pharmaceuticals (TERN) | 3.3 | $21M | 2.0M | 10.18 | |
| Annexon (ANNX) | 2.8 | $17M | 3.4M | 5.17 | |
| Trevi Therapeutics (TRVI) | 1.7 | $11M | 5.7M | 1.93 | |
| Dbv Technologies Sa Sponsored Adr | 1.7 | $11M | 7.1M | 1.53 | |
| Tyra Biosciences (TYRA) | 1.7 | $11M | 1.4M | 7.60 | |
| Imara | 0.4 | $2.6M | 631k | 4.09 |
